Skip to content

The safety and efficacy clinical trials of robotic cholecystectomy using 5G remote technology

The safety and efficacy clinical trials of robotic cholecystectomy using 5G remote technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070074
Enrollment
Unknown
Registered
2023-03-31
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder stones

Interventions

Remote Robotic Surgery Group:Robotic cholecystectomy completed with 5G remote technology

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Clear diagnosis of gallbladder stones by color Doppler ultrasound examination of the abdomen in a tertiary care hospital. (2) 18 years old = actual age = 80 years old. (3) Can be operated with conventional laparoscopic cholecystectomy. (4) Physiological condition acceptable for laparoscopic surgery. (5) Willing to cooperate and complete the study follow-up and related examinations. (6) Voluntarily participate in this trial and sign the informed consent in writing.

Exclusion criteria

Exclusion criteria: (1) Severe cardiovascular or circulatory disease and inability to tolerate general anesthesia. (2) Pregnant or lactating women. (3) Those who need to perform emergency surgery. (4) Preoperative suspicion of malignant gallbladder tumor. (5) Presence of active bleeding, severe abnormal coagulation (prothrombin time (PT) or international normalized ratio (INR) 1.5 times higher than the upper limit of normal) or platelet count <80×10^9/L; (6) Participation in another investigational drug or device clinical trial within the last 3 months. (7) Inability to understand the requirements of the trial or to complete the study follow-up schedule. (8) Other conditions deemed by the investigator to be inappropriate for enrollment.

Design outcomes

Primary

MeasureTime frame
Surgical success rate;Intraoperative bleeding;Surgery time;Duration of postoperative drainage tube retention;Laboratory tests (routine blood, liver and kidney function);Ancillary departmental examinations (abdominal ultrasonography, abdominal MRI);

Secondary

MeasureTime frame
Intraoperative system failure log;Intraoperative 5G network failure record;Time for master-slave control switching;Intraoperative instrumentation errors;Post-operative hospital days;Hospitalization Costs;

Countries

China

Contacts

Public ContactHui Cai/Yuntao Ma

Gansu Provincial Hospital

caialonteam@163.com13609397574/0931-8281005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026